glp-1 obesity drug news oct 21 2025 Alarming rise in weight loss overdoses New Daily GLP-1 Weight Loss

Pharmacologic interventions with angiotensin converting enzyme inhibitor or AT1 receptor antagonist has proven effective in attenuating scar tissue metabolic activity and minimizing adverse accumulation of fibrous tissue in noninfarcted myocardium

All peptides require reconstitution with bacteriostatic water

Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle

Retatrutides Phase 2 safety data looks great, but its still awaiting publication of its Phase 3 results and eventual FDA approval

Globally, there has been a considerable shift in societal perceptions and attitudes toward weight loss and body image, recognising that the underlying causes of obesity extend far beyond cosmetic concerns